Skip to main content

Frost Phillip MD Et Al's Form 4 filing

Opko Health, Inc. (OPK) · filed Oct 11, 2022

Accession no.
0001209191-22-053206
Filed
Oct 11, 2022, 7:47 AM ET
Trade date
Oct 7, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions. Open-market purchases total $132.6K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Frost Phillip MD Et AlCIK 0000898860Director, Officer (CEO & Chairman), 10% Owner
Frost Gamma Investments TrustCIK 000138089610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 7, 2022Common StockPPurchaseAcquired+25,000$1.76+$44,000197,781,694Indirect
Oct 7, 2022Common StockPPurchaseAcquired+22,359$1.77+$39,463.64197,804,053Indirect
Oct 7, 2022Common StockPPurchaseAcquired+7,641$1.77+$13,524.57197,811,694Indirect
Oct 7, 2022Common StockPPurchaseAcquired+2,400$1.78+$4,260197,814,094Indirect
Oct 7, 2022Common StockPPurchaseAcquired+12,800$1.78+$22,784197,826,894Indirect
Oct 7, 2022Common StockPPurchaseAcquired+4,800$1.79+$8,592197,831,694Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)